A phase 1/2 study of disulfiram and copper with concurrent radiation therapy and temozolomide for patients with newly diagnosed glioblastoma.
Huang J, Campian JL, DeWees TA, Skrott Z, Mistrik M, Johanns TM, Ansstas G, Butt O, Leuthardt E, Dunn GP, Zipfel GJ, Osbun JW, Abraham C, Badiyan S, Schwetye K, Cairncross JG, Rubin JB, Kim AH, Chheda MG.
Huang J, et al. Among authors: kim ah.
Int J Radiat Oncol Biol Phys. 2024 May 18:S0360-3016(24)00660-6. doi: 10.1016/j.ijrobp.2024.05.009. Online ahead of print.
Int J Radiat Oncol Biol Phys. 2024.
PMID: 38768767